Laboratory Historical Cash Flow

LH Stock  USD 216.57  3.05  1.43%   
Analysis of Laboratory cash flow over time is an excellent tool to project Laboratory future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 1 B or Depreciation of 609.9 M as it is a great indicator of Laboratory ability to facilitate future growth, repay debt on time or pay out dividends.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Laboratory latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Laboratory is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Laboratory Stock please use our How to Invest in Laboratory guide.

About Laboratory Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Laboratory balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Laboratory's non-liquid assets can be easily converted into cash.

Laboratory Cash Flow Chart

Laboratory Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Laboratory Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
As of now, Laboratory's Net Income is increasing as compared to previous years. The Laboratory's current Other Non Cash Items is estimated to increase to about 712.8 M, while Free Cash Flow is projected to decrease to under 619.8 M.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Laboratory to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Laboratory operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Laboratory financial statement analysis. It represents the amount of money remaining after all of Laboratory operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Laboratory's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Laboratory Stock please use our How to Invest in Laboratory guide.As of now, Laboratory's Net Income is increasing as compared to previous years. The Laboratory's current Other Non Cash Items is estimated to increase to about 712.8 M, while Free Cash Flow is projected to decrease to under 619.8 M.
 2021 2022 2023 2024 (projected)
Capital Expenditures460.4M481.9M453.6M476.3M
Depreciation745.1M633.9M580.9M609.9M

Laboratory cash flow statement Correlations

0.07-0.16-0.550.0-0.060.050.480.230.23-0.44-0.17-0.59-0.210.280.110.02-0.090.33-0.050.090.48-0.01
0.07-0.520.720.760.650.970.83-0.50.26-0.380.79-0.120.06-0.18-0.19-0.21-0.110.15-0.350.1-0.16-0.53
-0.16-0.52-0.36-0.6-0.64-0.44-0.520.18-0.810.76-0.550.66-0.450.690.080.460.28-0.230.54-0.770.310.73
-0.550.72-0.360.580.540.680.46-0.50.09-0.010.710.260.18-0.29-0.36-0.09-0.280.0-0.20.14-0.44-0.46
0.00.76-0.60.580.950.690.570.0-0.390.47-0.290.93-0.140.44-0.52-0.37-0.15-0.290.14-0.430.38-0.45-0.68
-0.060.65-0.640.540.950.560.45-0.530.58-0.220.86-0.080.64-0.68-0.27-0.27-0.270.26-0.540.54-0.64-0.79
0.050.97-0.440.680.690.560.77-0.460.14-0.390.69-0.09-0.03-0.08-0.11-0.210.040.09-0.37-0.05-0.06-0.44
0.480.83-0.520.460.570.450.77-0.240.27-0.490.56-0.36-0.110.04-0.26-0.05-0.370.33-0.240.170.11-0.41
0.0
0.23-0.50.18-0.5-0.39-0.53-0.46-0.24-0.22-0.23-0.35-0.43-0.50.3-0.060.44-0.09-0.210.39-0.260.640.61
0.230.26-0.810.090.470.580.140.27-0.22-0.490.41-0.520.76-0.750.13-0.32-0.150.22-0.410.89-0.55-0.85
-0.44-0.380.76-0.01-0.29-0.22-0.39-0.49-0.23-0.49-0.220.920.020.250.010.210.05-0.10.27-0.34-0.310.25
-0.170.79-0.550.710.930.860.690.56-0.350.41-0.22-0.050.39-0.49-0.35-0.07-0.290.04-0.340.31-0.48-0.6
-0.59-0.120.660.26-0.14-0.08-0.09-0.36-0.43-0.520.92-0.050.030.180.090.090.12-0.040.09-0.4-0.370.15
-0.210.06-0.450.180.440.64-0.03-0.11-0.50.760.020.390.03-0.760.13-0.25-0.020.18-0.380.74-0.89-0.79
0.28-0.180.69-0.29-0.52-0.68-0.080.040.3-0.750.25-0.490.18-0.76-0.050.30.17-0.270.46-0.750.720.71
0.11-0.190.08-0.36-0.37-0.27-0.11-0.26-0.060.130.01-0.350.090.13-0.05-0.210.530.25-0.28-0.07-0.04-0.05
0.02-0.210.46-0.09-0.15-0.27-0.21-0.050.44-0.320.21-0.070.09-0.250.3-0.21-0.220.070.62-0.390.310.41
-0.09-0.110.28-0.28-0.29-0.270.04-0.37-0.09-0.150.05-0.290.12-0.020.170.53-0.22-0.31-0.16-0.40.080.2
0.330.15-0.230.00.140.260.090.33-0.210.22-0.10.04-0.040.18-0.270.250.07-0.31-0.230.28-0.15-0.29
-0.05-0.350.54-0.2-0.43-0.54-0.37-0.240.39-0.410.27-0.340.09-0.380.46-0.280.62-0.16-0.23-0.330.360.5
0.090.1-0.770.140.380.54-0.050.17-0.260.89-0.340.31-0.40.74-0.75-0.07-0.39-0.40.28-0.33-0.62-0.79
0.48-0.160.31-0.44-0.45-0.64-0.060.110.64-0.55-0.31-0.48-0.37-0.890.72-0.040.310.08-0.150.36-0.620.75
-0.01-0.530.73-0.46-0.68-0.79-0.44-0.410.61-0.850.25-0.60.15-0.790.71-0.050.410.2-0.290.5-0.790.75
Click cells to compare fundamentals

Laboratory Account Relationship Matchups

Laboratory cash flow statement Accounts

201920202021202220232024 (projected)
Change In Cash(89.3M)983.3M151.9M(1.0B)216.2M227.0M
Free Cash Flow1.0B1.8B2.6B1.5B874.1M619.8M
Change In Working Capital(294.4M)(856.9M)(263.7M)(603.4M)(361.9M)(343.8M)
Begin Period Cash Flow426.8M337.5M1.3B1.5B320.6M265.8M
Other Cashflows From Financing Activities4.7B242.3M1.9B709.8M1.4B1.0B
Depreciation577.2M624.7M745.1M633.9M580.9M609.9M
Capital Expenditures400.2M381.7M460.4M481.9M453.6M476.3M
Total Cash From Operating Activities1.4B2.1B3.1B2.0B1.3B801.6M
Net Income824.9M1.6B2.4B1.3B379.2M514.7M
Total Cash From Financing Activities(252.7M)(517.4M)(2.1B)(1.3B)(59.3M)(62.3M)
End Period Cash Flow337.5M1.3B1.5B430M536.8M295.5M
Dividends Paid2.4B151.7M1B195.2M(254M)(241.3M)
Sale Purchase Of Stock(450M)(100M)(1.7B)(1.1B)(1B)(950M)
Other Non Cash Items200.8M745.8M170.9M482.4M678.9M712.8M
Change To Inventory(21.9M)(196.6M)2.8M(45.5M)(700K)(735K)
Stock Based Compensation107M111.7M153.7M144.1M128.7M82.9M
Other Cashflows From Investing Activities1.7M3.1M(424.2M)(1.2B)(1.1B)(1.0B)
Change To Account Receivables(64.1M)(913.4M)222M15.9M(75.3M)(79.1M)
Change To Liabilities25.3M43.1M34.8M342.4M393.8M413.4M
Investments(1.3B)(643.2M)(14.6M)(1.7B)(1.1B)(1.1B)
Net Borrowings(409.3M)210.1M(412.2M)(375M)(337.5M)(320.6M)
Total Cashflows From Investing Activities(1.3B)(643.2M)(884.6M)(1.7B)(1.5B)(1.6B)
Change To Netincome144M611.1M56M646.3M743.2M780.4M
Change To Operating Activities(174.7M)252.5M(344.1M)(816.2M)(734.6M)(697.9M)
Issuance Of Capital Stock64.7M55.9M51.7M50.6M54.4M46.2M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Laboratory Stock please use our How to Invest in Laboratory guide.
Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Transaction History
View history of all your transactions and understand their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.46)
Dividend Share
2.88
Earnings Share
4.33
Revenue Per Share
139.628
Quarterly Revenue Growth
0.035
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.